SEC Form 4 · accession 0000914190-17-000028
REGENERX BIOPHARMACEUTICALS INC · RGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allan L Goldstein
Director
Period of report
Jan 31, 2017
Accepted (ET)
Feb 6, 2017 · 1:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707511
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2017 | G | 125,000 | $0.00 | D | 681,743 | D |
Table II — derivative securities
No Table II lines on this filing.